[Federal Register Volume 62, Number 98 (Wednesday, May 21, 1997)] [Notices] [Page 27776] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-13312] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 17, 1997, Research Biochemicals, Limited Partnership, 1-3 Strathmore Road, Natick, Massachusetts 01760, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Cathinone (1235)......................... I Methcathinone (1237)..................... I Alpha-Ethyltryptamine (7249)............. I Lysergic acid diethylamide (7315)........ I 2,5-Dimethoxyamphetamine (7396).......... I 3,4-Methylenedioxymethamphetamine (7405). I Dimethyltryptamine (7435)................ I 1-[-(2-Thienyl) cyclohexyl] piperidene I (7470). Heroin (9200)............................ I Normorphine (9313)....................... I Phencyclidine (7471)..................... II Benzoylecgonine (9180)................... II ------------------------------------------------------------------------ The firm plans to manufacture the listed controlled substances for laboratory reference standards and neurochemicals. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the above application. Any such comments or objections may be addressed, in quintuplicate, to the Acting Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than July 21, 1997. Dated: April 24, 1997. Terrance W. Woodworth, Acting Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 97-13312 Filed 5-20-97; 8:45 am] BILLING CODE 4410-09-M